Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:90
|
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 50 条
  • [21] Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure
    Erbel, Raimund
    Budoff, Matthew
    EUROPEAN HEART JOURNAL, 2012, 33 (10) : 1201 - +
  • [22] Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
    Hagstrom, E.
    Norlund, F.
    Stebbins, A.
    Armstrong, P. W.
    Chiswell, K.
    Granger, C. B.
    Lopez-Sendon, J.
    Pella, D.
    Soffer, J.
    Sy, R.
    Wallentin, L.
    White, H. D.
    Stewart, R. A. H.
    Held, C.
    JOURNAL OF INTERNAL MEDICINE, 2018, 283 (01) : 83 - 92
  • [23] Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and Spain
    Grau, Maria
    Bongard, Vanina
    Fito, Montserrat
    Ruidavets, Jean-Bernard
    Sala, Joan
    Taraszkiewicz, Dorota
    Masia, Rafael
    Galinier, Michel
    Subirana, Isaac
    Carrie, Didier
    Vila, Joan
    Marrugat, Jaume
    Ferrieres, Jean
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (02) : 80 - 89
  • [24] Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
    Sabatine, Marc S.
    Morrow, David A.
    de Lemos, James A.
    Omland, Torbjorn
    Sloan, Sarah
    Jarolim, Petr
    Solomon, Scott D.
    Pfeffer, Marc A.
    Braunwald, Eugene
    CIRCULATION, 2012, 125 (02) : 233 - U137
  • [25] Usefulness of Beta Blockade in Contemporary Management of Patients With Stable Coronary Heart Disease
    Winchester, David E.
    Pepine, Carl J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (10) : 1607 - 1612
  • [26] Heterogenous Distribution of Risk for Cardiovascular Disease Events in Patients With Stable Ischemic Heart Disease
    Mortensen, Martin Bodtker
    Steffensen, Flemming Hald
    Botker, Hans Erik
    Jensen, Jesper Moller
    Sand, Niels Peter Ronnow
    Kragholm, Kristian Hay
    Kanstrup, Helle
    Sorensen, Henrik Toft
    Leipsic, Jonathon
    Blaha, Michael J.
    Norgaard, Bjarne Linde
    JACC-CARDIOVASCULAR IMAGING, 2021, 14 (02) : 442 - 450
  • [27] Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease
    Ahluwalia, Namanjeet
    Blacher, Jacques
    de Edelenyi, Fabien Szabo
    Faure, Patrice
    Julia, Chantal
    Hercberg, Serge
    Galan, Pilar
    ATHEROSCLEROSIS, 2013, 228 (02) : 478 - 484
  • [28] Residual risk of cardiovascular mortality in patients with coronary heart disease: The EUROASPIRE Risk Categories
    De Bacquer, Dirk
    Dallongeville, Jean
    Kotseva, Kornelia
    Cooney, Marie Therese
    Pajak, Andrzej
    Deckers, Jaap W.
    Mayer, Otto
    Vanuzzo, Diego
    Lehto, Seppo
    Fras, Zlatko
    Ostor, Erika
    Ambrosio, Giovanni B.
    De Backer, Guy
    Wood, David
    Keil, Ulrich
    Sans, Susana
    Graham, Ian
    Pyorala, Kalevi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 910 - 914
  • [29] Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease
    Ganz, Peter
    Heidecker, Bettina
    Hveem, Kristian
    Jonasson, Christian
    Kato, Shintaro
    Segal, Mark R.
    Sterling, David G.
    Williams, Stephen A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (23): : 2532 - 2541
  • [30] Multiple marker approach to risk stratification in patients with stable coronary artery disease
    Schnabel, Renate B.
    Schulz, Andreas
    Messow, C. Martina
    Lubos, Edith
    Wild, Philipp S.
    Zeller, Tanja
    Sinning, Christoph R.
    Rupprecht, Hans J.
    Bickel, Christoph
    Peetz, Dirk
    Cambien, Francois
    Kempf, Tibor
    Wollert, Kai C.
    Benjamin, Emelia J.
    Lackner, Karl J.
    Muenzel, Thomas
    Tiret, Laurence
    Vasan, Ramachandran S.
    Blankenberg, Stefan
    EUROPEAN HEART JOURNAL, 2010, 31 (24) : 3024 - 3031